125 related articles for article (PubMed ID: 37925103)
1. Flowchart for predicting achieving the target area under the concentration-time curve of vancomycin in critically ill Japanese patients: A multicenter retrospective study.
Ishigo T; Fujii S; Ibe Y; Aigami T; Nakano K; Fukudo M; Yoshida H; Tanaka H; Ebihara F; Maruyama T; Hamada Y; Suzuki A; Fujihara H; Yamaguchi F; Samura M; Nagumo F; Komatsu T; Tomizawa A; Takuma A; Chiba H; Nishi Y; Enoki Y; Taguchi K; Matsumoto K
J Infect Chemother; 2024 Apr; 30(4):329-336. PubMed ID: 37925103
[TBL] [Abstract][Full Text] [Related]
2. Effect of renal clearance on vancomycin area under the concentration-time curve deviations in critically ill patients.
Ishigo T; Ibe Y; Fujii S; Kazuma S; Aigami T; Kashiwagi Y; Takada R; Takahashi S; Fukudo M; Toda T
J Infect Chemother; 2023 Aug; 29(8):769-777. PubMed ID: 37150254
[TBL] [Abstract][Full Text] [Related]
3. Simulation of Vancomycin Exposure Using Trough and Peak Levels Achieves the Target Area under the Steady-State Concentration-Time Curve in ICU Patients.
Ibe Y; Ishigo T; Fujii S; Takahashi S; Fukudo M; Sato H
Antibiotics (Basel); 2023 Jun; 12(7):. PubMed ID: 37508208
[TBL] [Abstract][Full Text] [Related]
4. Should the trough concentration of vancomycin be abandoned in therapeutic drug monitoring? A multicentre, retrospective study of critically ill patients without any form of dialysis.
Yu Z; Liu J; Yu H; Zhou L; Zhao Y; Zhong L; Zhu J; Liang G; Yang Y; Zheng Y; Yu L; Han G
Int J Antimicrob Agents; 2023 Jun; 61(6):106812. PubMed ID: 37037321
[TBL] [Abstract][Full Text] [Related]
5. Machine Learning-Based Model for Estimating Vancomycin Maintenance Dose to Target the Area under the Concentration Curve of 400-600 mg·h/L in Japanese Patients.
Miyai T; Imai S; Yoshimura E; Kashiwagi H; Sato Y; Ueno H; Takekuma Y; Sugawara M
Biol Pharm Bull; 2022; 45(9):1332-1339. PubMed ID: 36047202
[TBL] [Abstract][Full Text] [Related]
6. Relationship between nephrotoxicity and area under the concentration-time curve of vancomycin in critically ill patients: a multicenter retrospective study.
Ishigo T; Matsumoto K; Yoshida H; Tanaka H; Ibe Y; Fujii S; Fukudo M; Fujihara H; Yamaguchi F; Ebihara F; Maruyama T; Hamada Y; Samura M; Nagumoi F; Komatsu T; Tomizawa A; Takuma A; Chiba H; Nishi Y; Enoki Y; Taguchi K; Suzuki A
Microbiol Spectr; 2024 May; ():e0373923. PubMed ID: 38775483
[TBL] [Abstract][Full Text] [Related]
7. Vancomycin therapeutic monitoring by measured trough concentration versus Bayesian-derived area under the curve in critically ill patients with cancer.
AbuSara AK; Abdelrahman DH; Habash KI; Al-Shaer MH; Le J; Nazer LH
Pharmacol Res Perspect; 2022 Feb; 10(1):e00912. PubMed ID: 34990089
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Vancomycin Area Under the Concentration-Time Curve Predictive Performance Using Bayesian Modeling Software With and Without Peak Concentration: An Academic Hospital Experience for Adult Patients Without Renal Impairment.
Kim HK; Jeong TD
Ann Lab Med; 2023 Nov; 43(6):554-564. PubMed ID: 37387488
[TBL] [Abstract][Full Text] [Related]
9. Conversion from Vancomycin Trough Concentration-Guided Dosing to Area Under the Curve-Guided Dosing Using Two Sample Measurements in Adults: Implementation at an Academic Medical Center.
Meng L; Wong T; Huang S; Mui E; Nguyen V; Espinosa G; Desai J; Holubar M; Deresinski S
Pharmacotherapy; 2019 Apr; 39(4):433-442. PubMed ID: 30739349
[TBL] [Abstract][Full Text] [Related]
10. Clinical application of vancomycin TDM in ventilated patients with gastrointestinal cancer: a propensity-matched analysis.
Zhang X; Wu Y; Wang D
BMC Infect Dis; 2024 Jan; 24(1):10. PubMed ID: 38166695
[TBL] [Abstract][Full Text] [Related]
11. Individualized Delivery of Vancomycin by Model-Informed Bayesian Dosing Approach to Maintain an AUC24 Target in Critically Ill Patients.
Rao Z; Guo SM; Wei YM
Chemotherapy; 2024; 69(1):49-55. PubMed ID: 37591210
[TBL] [Abstract][Full Text] [Related]
12. Prediction Accuracy of Area under the Concentration-Time Curve of Vancomycin by Bayesian Approach Using Creatinine-Based Equations of Estimated Kidney Function in Bedridden Elderly Japanese Patients.
Sonoda A; Iwashita Y; Takada Y; Hamazono R; Ishida K; Imamura H
Biol Pharm Bull; 2022 Jun; 45(6):763-769. PubMed ID: 35370223
[TBL] [Abstract][Full Text] [Related]
13. Development and Evaluation of a Novel Software Program, SAKURA-TDM, for Area Under the Concentration-Time Curve-Guided Vancomycin Dosing: A Short Communication.
Horita Y; Asaoka M; Iida M; Kato H; Wachino C; Mitamura K; Ohashi K; Mimura Y; Hotta Y; Kataoka T; Nakamura A; Kimura K
Ther Drug Monit; 2023 Apr; 45(2):245-250. PubMed ID: 36006610
[TBL] [Abstract][Full Text] [Related]
14. Performance of Area under the Concentration-Time Curve Estimations of Vancomycin with Limited Sampling by a Newly Developed Web Application.
Oda K; Hashiguchi Y; Kimura T; Tsuji Y; Shoji K; Takahashi Y; Matsumoto K; Kawamura H; Saito H; Takesue Y
Pharm Res; 2021 Apr; 38(4):637-646. PubMed ID: 33782837
[TBL] [Abstract][Full Text] [Related]
15. Reduced nephrotoxicity with vancomycin therapeutic drug monitoring guided by area under the concentration-time curve against a trough 15-20 μg/mL concentration.
Oda K; Jono H; Nosaka K; Saito H
Int J Antimicrob Agents; 2020 Oct; 56(4):106109. PubMed ID: 32721597
[TBL] [Abstract][Full Text] [Related]
16. Clinical validation of the two-point method for predicting vancomycin AUC based on peak and trough plasma concentrations.
Wang L; Lin X; Wang L; Ye H; Lin Y; Ruan J; Shi S
Int J Clin Pharm; 2022 Dec; 44(6):1325-1331. PubMed ID: 36136207
[TBL] [Abstract][Full Text] [Related]
17. Efficiency of dosing software using Bayesian forecasting in achieving target antibiotic exposures in critically ill patients, a prospective cohort study.
Chai MG; Roberts JA; Kelly CF; Ungerer JPJ; McWhinney BC; Lipman J; Farkas A; Cotta MO
Anaesth Crit Care Pain Med; 2023 Dec; 42(6):101296. PubMed ID: 37579945
[TBL] [Abstract][Full Text] [Related]
18. Impact of model-informed precision dosing on achievement of vancomycin exposure targets in pediatric patients with cystic fibrosis.
Frymoyer A; Schwenk HT; Brockmeyer JM; Bio L
Pharmacotherapy; 2023 Oct; 43(10):1007-1014. PubMed ID: 37401162
[TBL] [Abstract][Full Text] [Related]
19. Review and Validation of Bayesian Dose-Optimizing Software and Equations for Calculation of the Vancomycin Area Under the Curve in Critically Ill Patients.
Turner RB; Kojiro K; Shephard EA; Won R; Chang E; Chan D; Elbarbry F
Pharmacotherapy; 2018 Dec; 38(12):1174-1183. PubMed ID: 30362592
[TBL] [Abstract][Full Text] [Related]
20. Risk of Acute Kidney Injury Based on Vancomycin Target Trough Attainment Strategy: Area-Under-the-Curve-Guided Bayesian Software, Nomogram, or Trough-Guided Dosing.
Knight JM; Iso T; Perez KK; Swan JT; Janak CE; Ikwuagwu JO; Musick WL
Ann Pharmacother; 2024 Feb; 58(2):110-117. PubMed ID: 37144736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
